HYND GEORGE,TISSELLI PATRIZIA,CLARK DAVID EDWARD,KULAGOWSKI JANUSZ JOZEF,MACLEOD CALUM,MANN SAMUEL EDWARD,ROUSSEL FABIEN JEAN GHISLAIN,PRICE STEPHEN COLIN,MONTANA JOHN GARY
申请号：
IN201627012803
公开号：
IN201627012803A
申请日:
2016.04.12
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal and in particular to inhibitors of NF B inducing kinase (NIK also known as MAP3K14) useful for treating diseases such as cancer inflammatory disorders metabolic disordersand autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds to processes to prepare such compounds and compositions and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer inflammatory disorders metabolic disorders including obesity and diabetes and autoimmune disorders.
